Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C Kneitz1, J Atta2, H Burkhardt3

  • 1Klinik für Innere Medizin II (Rheumatologie und Klinische Immunologie, Geriatrie), Klinikum Südstadt Rostock, Am Südring 91, 18059, Rostock, Deutschland. christian.kneitz@kliniksued-rostock.de.

Zeitschrift Fur Rheumatologie
|October 4, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Diagnosis and treatment of ANCA-associated vasculitis : S3 guideline of the German Society for Rheumatology and Clinical Immunology e. V. (DGRh) and German Society for Internal Medicine e. V. (DGIM), German Society for Nephrology e. V. (DGfN), German Society for ENT Medicine and Head and Neck Surgery e. V. (DGHNO-KHC), German Ophthalmological Society e. V. (DOG), German Society for Neurology e. V. (DGN), German Society for Pneumology and Respiratory Medicine e. V. (DGP), German Society for Pathology e. V. (DGP), German Radiological Society, Society for Medical Radiology e. V. (DRG), Federal Association of German Pathologists, Federal Kidney Association e. V., German Rheumatism League Federal Association e. V.]

Zeitschrift fur Rheumatologie·2025
Same author

[Diagnosis and treatment of ANCA-associated vasculitis : SHORT VERSION of the S3 guideline of the German Society for Rheumatology and Clinical Immunology e. V. (DGRh) and German Society for Internal Medicine e. V. (DGIM), German Society for Nephrology e. V. (DGfN), German Society for Otorhinolaryngology and Head and Neck Surgery e. V. (DGHNO-KHC), German Ophthalmological Society e. V. (DOG), German Society for Neurology e. V. (DGN), German Society for Pneumology and Respiratory Medicine e. V. (DGP), German Society for Pathology e. V. (DGP), German Radiological Society, Society for Medical Radiology e. V. (DRG), Federal Association of German Pathologists, Federal Kidney Association e. V., German Rheumatism League Federal Association e. V.]

Zeitschrift fur Rheumatologie·2025
Same author

[Corona vaccination under immunosuppression].

Zeitschrift fur Rheumatologie·2024
Same author

[Influence of underlying disease and immunosuppression on the immunocompetence in inflammatory rheumatic diseases].

Zeitschrift fur Rheumatologie·2023
Same author

First Search for Exclusive Diphoton Production at High Mass with Tagged Protons in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2022
Same author

Odderon Exchange from Elastic Scattering Differences between pp and pp[over ¯] Data at 1.96 TeV and from pp Forward Scattering Measurements.

Physical review letters·2021
Same journal

[Prevention strategies in rheumatoid arthritis : From primary prevention to targeted drug interception].

Zeitschrift fur Rheumatologie·2026
Same journal

Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.

Zeitschrift fur Rheumatologie·2026
Same journal

Evaluating the comparative efficacy of belimumab vs. anifrolumab in systemic lupus erythematosus: a response.

Zeitschrift fur Rheumatologie·2026
Same journal

[Update: DMARDs for MGUS].

Zeitschrift fur Rheumatologie·2026
Same journal

[A potpourri of diagnoses-Unusual manifestations of a chronic inflammatory bowel disease : Case report].

Zeitschrift fur Rheumatologie·2026
Same journal

[Not measurable but immeasurably important : Fever-The leading symptom of ancient medical theory].

Zeitschrift fur Rheumatologie·2026
See all related articles

Rheumatic diseases can cause severe blood cell deficiencies, including anemia, thrombocytopenia, and leukocytopenia. Understanding these hematological alterations is crucial for managing patient outcomes and treatment strategies.

Area of Science:

  • Hematology
  • Rheumatology
  • Internal Medicine

Background:

  • Hematological alterations are common in rheumatic diseases, potentially leading to severe clinical consequences.
  • These alterations include anemia, thrombocytopenia, and leukocytopenia, impacting patient health significantly.
  • Both the underlying rheumatic disease and immunosuppressive treatments can cause these blood count changes.

Purpose of the Study:

  • To review the key aspects of differentiating hematological alterations in patients with rheumatic diseases.
  • To provide a summary of anemia, leukocytopenia, and thrombocytopenia in the context of rheumatic conditions.
  • To aid in the differential diagnostic clarification of cytopenia in this patient population.

Main Methods:

  • Review of existing literature on hematological alterations in rheumatic diseases.
Keywords:
Differential diagnosisGranulocytopeniaHemorrhageInfectionsRheumatic diseases

Related Experiment Videos

  • Summarization of causes, clinical sequelae, and diagnostic challenges.
  • Focus on anemia of chronic inflammation, antibody-mediated thrombocytopenia (e.g., SLE), and granulocytopenia (e.g., Felty's syndrome).
  • Discussion of treatment-induced cytopenias (e.g., cyclophosphamide, tocilizumab, JAK inhibitors).

    • Main Results:

    • Hematological alterations like anemia, thrombocytopenia, and leukocytopenia are frequent and can be severe in rheumatic diseases.
    • Causes are multifactorial, including the primary disease process and immunosuppressive therapies.
    • Differential diagnosis of cytopenia requires a systematic approach, considering disease course and treatment history.
    • Specific examples include anemia of chronic inflammation, SLE-related thrombocytopenia, and Felty's syndrome-associated granulocytopenia.

    Conclusions:

    • Hematological alterations are a significant clinical concern in rheumatic diseases, affecting anemia, white blood cell, and platelet counts.
    • Accurate diagnosis and management of cytopenias are essential for improving patient outcomes.
    • A thorough understanding of both disease- and treatment-related hematological changes is necessary for effective patient care.